BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang S, Liao W, Wu Q, Huang X, Pan Z, Chen W, Gu S, Huang Z, Wang Y, Tang X, Liang S, Zhang X, Chen Y, Chen S, Chen W, Jiang Y, Chen C, Qiu G. LINC00152 upregulates ZEB1 expression and enhances epithelial-mesenchymal transition and oxaliplatin resistance in esophageal cancer by interacting with EZH2. Cancer Cell Int 2020;20:569. [PMID: 33292221 DOI: 10.1186/s12935-020-01620-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Lu J, Fei F, Wu C, Mei J, Xu J, Lu P. ZEB1: Catalyst of immune escape during tumor metastasis. Biomedicine & Pharmacotherapy 2022;153:113490. [DOI: 10.1016/j.biopha.2022.113490] [Reference Citation Analysis]
2 Liu X, Zhao T, Yuan Z, Ge S. MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44. Cell Death Discov 2022;8:216. [PMID: 35443748 DOI: 10.1038/s41420-022-01000-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Qin J, Li Y, Li Z, Qin X, Zhou X, Zhang H, Li S. LINC00114 stimulates growth and glycolysis of esophageal cancer cells by recruiting EZH2 to enhance H3K27me3 of DLC1. Clin Epigenetics 2022;14:51. [PMID: 35414117 DOI: 10.1186/s13148-022-01258-y] [Reference Citation Analysis]
4 Xu J, Pan HW, Wang XQ, Chen KP. Status of diagnosis and treatment of esophageal cancer and non-coding RNA correlation research: a narrative review. Transl Cancer Res 2021;10:4532-52. [PMID: 35116309 DOI: 10.21037/tcr-21-687] [Reference Citation Analysis]
5 Paskeh MDA, Mehrabi A, Gholami MH, Zabolian A, Ranjbar E, Saleki H, Ranjbar A, Hashemi M, Ertas YN, Hushmandi K, Mirzaei S, Ashrafizadeh M, Zarrabi A, Samarghandian S. EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects. Biomed Pharmacother 2021;146:112532. [PMID: 34906772 DOI: 10.1016/j.biopha.2021.112532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Wei L, Sun J, Zhang N, Shen Y, Wang T, Li Z, Yang M. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer. Front Cell Dev Biol 2021;9:764313. [PMID: 34881242 DOI: 10.3389/fcell.2021.764313] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Fratini L, Jaeger M, de Farias CB, Brunetto AT, Brunetto AL, Shaw L, Roesler R. Oncogenic functions of ZEB1 in pediatric solid cancers: interplays with microRNAs and long noncoding RNAs. Mol Cell Biochem 2021. [PMID: 34292482 DOI: 10.1007/s11010-021-04226-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Son SW, Yun BD, Song MG, Lee JK, Choi SY, Kuh HJ, Park JK. The Hypoxia-Long Noncoding RNA Interaction in Solid Cancers. Int J Mol Sci 2021;22:7261. [PMID: 34298879 DOI: 10.3390/ijms22147261] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
9 Cui C, Wang Y, Gong W, He H, Zhang H, Shi W, Wang H. Long Non-Coding RNA LINC00152 Regulates Self-Renewal of Leukemia Stem Cells and Induces Chemo-Resistance in Acute Myeloid Leukemia. Front Oncol 2021;11:694021. [PMID: 34295821 DOI: 10.3389/fonc.2021.694021] [Cited by in F6Publishing: 3] [Reference Citation Analysis]